Free Trial
NASDAQ:ICAD

icad Q1 2025 Earnings Report

icad logo
$3.87 0.00 (0.00%)
As of 07/17/2025

icad EPS Results

Actual EPS
-$0.02
Consensus EPS
-$0.06
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

icad Revenue Results

Actual Revenue
$4.87 million
Expected Revenue
$4.54 million
Beat/Miss
Beat by +$331.00 thousand
YoY Revenue Growth
N/A

icad Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

icad's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

icad Earnings Headlines

iCAD Stockholders Approve Merger with RadNet
The stealth altcoin the financial world is underestimating
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.
See More icad Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like icad? Sign up for Earnings360's daily newsletter to receive timely earnings updates on icad and other key companies, straight to your email.

About icad

icad (NASDAQ:ICAD), Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

View icad Profile

More Earnings Resources from MarketBeat